The failure of ubiquitin proteasome (UP) function is widely believed to participate in the development of Parkinson's disease (PD) [1] [2] [3] . Recent studies have shown that most causative genes of familial PD are associated with ubiquitin proteasome system, including α-synuclein 4 , parkin 5 , ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) 6 and DJ-1 7 . Above all, evidence shows that proteasome inhibition has been found in the substantia nigra pars compacta (SNpc) of sporadic PD [8] [9] [10] , which accounts for 95 percent of all PD cases. All of these have triggered big interest in exploring the role of UP dysfunction in the pathogenesis of PD. Recently several studies have revealed that proteasome inhibitors could produce excellent PD animal models [11] [12] [13] , ABSTRACT: Objective: Ubiquitin proteasome system dysfunction is believed to play an important role in the development of Parkinson's disease (PD), and almost all studies till now have mainly focused on the susceptibility of dopaminergic neurons to proteasome inhibition. However, in fact, there are many other types of neurons such as cholinergic ones involved in PD. In our present study, we attempt to figure out what effect the failure of ubiquitin proteasome function would execute on cholinergic cells in culture.
Almost all studies up to now have mainly focused on the susceptibility of dopaminergic neurons to proteasome inhibition, although in fact, there are many other types of neurons involved in PD, such as cholinergic neurons [19] [20] [21] . During the neurodegenerative process of PD, some cholinergic neurons are damaged as severely as dopaminergic neurons 20, 21 . Therefore, cholinergic neurons may be as sensitive to the failure of UP function as dopaminergic neurons. In the present study, we attempt to figure out what effect the failure of UP function would exert on cholinergic cells in culture.
MATERIALS AND METHODS
Cell culture. Mouse cholinergic SN56 cells were kindly provided by Proffessor Jianzhi Wang (Department of Pathophysiology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, China). The cell lines were cultured at 37°C in 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% inactive fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin (Invitrogen, Carlsbad, CA).
Cell viability analysis. Cells were seeded in 96-well plates and cultured for 48h. Then they were treated with various concentrations (1μΜ, 5μΜ, 10μΜ, 20μΜ) of lactacystin (Lact) (Sigma, St Louis, MO) for 24h. After incubation, the cell viability was assessed by quantitative colorimetric assay with 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT, Sigma) according to the manufacturer's protocol.
Detection of apoptosis. The cells were treated as described in the MTT assay. After 24 hours of treatment, the supernatants were discarded, and the cells were washed with phosphatebuffered saline (PBS) and harvested after digestion with non-EDTA trypsin. Then the cells were stained with 2 μl Annexin V and 1 μl PI reagent (Santa Cruz, California, USA) for 15 min in the dark at room temperature. Fluorescence densities were measured with a FACS Calibur flow cytometer.
Measurement of mitochondrial membrane potential. The mitochondrial membrane potential was analyzed using JC-1, a lipophilic fluorescence probe (MitoProbe, Molecular Probes, Eugene, OR). The cells were seeded in 6-well plates and treated for 24 hours with various concentrations of Lact. The medium was then replaced with medium containing JC-1 at a final concentration of 10 μg/ml, followed by incubation at 37ºC under 5% CO 2 for ten minutes. The trypsinized cells were harvested, washed with cold PBS and analyzed using a FACS Calibur flow cytometer.
Measurement of reactive oxygen species (ROS). The intracellular production of ROS was determined using the fluorescent probe CM-H2DCFDA (Molecular Probes). CM-H2DCFDA is a nonfluorescent reagent that forms fluorescent esters after reacting with ROS inside cells. The procedure was like JC-1 staining, except that the final concentration of CM-H2DCFDA was 1 μM and the incubation time in the dark at room temperature was ten minutes.
Western blot analysis. Cells were treated for 24 hour with various concentrations of Lact. Total cell lysates were prepared with radioimmunoprecipitation (RIPA) buffer (Sigma) containing 1 x complete protease inhibitors (Roche, Germany), according to the manufacturer's protocol. Insoluble material was recovered by centrifugation at 12,000 x g for 20 minutes. Pellets were resuspended in 2% sodium dodecylsulfate (SDS) buffer (50 mM Tris-HCl, pH 7.6, 2% SDS). Protein lysates were quantified using the bicinchoninic acid protein assay（bicinchoninic acid assay was used to quantify protein lysates.）(Pierce, Rockford, IL). Samples containing equal amounts of total proteins were separated on 8% SDS-polyacrylamide gels and analyzed by western blotting with antibodies against polyubiquitinated conjugates (clone FK1, 1:1000, BioMol, Plymouth Meeting, PA), followed by the corresponding secondary antibody. Electrochemiluminescence detection was performed according to the manufacturer's protocol (Pierce). The membranes were THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES washed with stripping buffer (Pierce) and incubated with a β-actin monoclonal antibody (1:3000, Sigma) to confirm equal loading.
Statistical analysis. All experiments were performed at least in triplicate. The statistical package SPSS11.5 was used for all analyses. All values were expressed as mean ± SD. One-way analysis of variance (ANOVA), followed by post-hoc LSD multiple comparison test was used to determine the significance of differences. A value of P<0.05 was considered statistically significant.
RESULTS

Proteasomal inhibition induces apoptotic cell death
As we expected, cholinergic SN56 cells showed sensitivity to the toxicity of Lact, the specific proteasome inhibitor, and a dose of 1μM was enough to induce significant cell death. However, with the concentration increasing, the survival rate of SN56 cells did not decrease in a dose-dependent manner. Lact at a dose of 5μM reached the peak of cytotoxicity, and higher doses did not further aggravate the situation ( Figure 1A ). With the AnnexinV-PI double staining, we found that cholinergic cells exposed to Lact experienced apoptosis, and confirmed that Lact at a dose of 5μM reached the plateau neurotoxicity ( Figure 1B ).
Proteasomal inhibition induces mitochondrial-dependent apoptosis
In order to determine whether Lact-induced apoptosis of SN56 cells could be ascribed to an alteration of mitochondrial activity, mitochondrial membrane potential was measured by ratiometric probe JC-1. Then we found that Lact at a dose of 1μM significantly damaged the membrane potential of mitochondria, and again 5μM Lact reached the damage peak, with the similar percentage showed by AnnexinV-PI double staining. However, in contrast to AnnexinV-PI double staining, with higher doses than 5μM, the function of mitochondria was restored and at a dose of 20μM, a significant portion of cells escaped the mitochondrial damage compared with 5μM Lact (Figure 2 ).
Proteasomal inhibition induces oxidative stress
To determine whether proteasomal inhibition could induce oxidative stress, we used CM-H2DCFDA to detect cellular reactive oxygen species (ROS). Similar to the tendency of mitochondrial membrane potential, Lact at a dose of 5μM induced strongest oxidative stress, while with the concentration increasing, oxidative stress attenuated (Figure 3 ).
Proteasomal inhibition induces polyubiquitinated proteins production
To explore the relationship between proteasomal inhibition and the accumulation of polyubiquitinated proteins in cholinergic cells, we used Western blot to detect both soluble and insoluble intracellular polyubiquitinated proteins. Then we were surprised to find that low doses including 5μM did not lead to significant accumulation of polyubiquitinate proteins, although they induced significant cell death. On the contrary, at higher doses of 10μM and 20μM, both soluble and insoluble intracellular polyubiquitinated proteins markedly increased, although the percentage of cell death did not further increase (Figure 4 ).
DISCUSSION
Loss of dopaminergic neurons in the substantia nigra pars compacta and the appearance of Lewy bodies in the remaining neurons are the two pathologic hallmarks of PD. Therefore, numerous studies have been devoted to disclosing the myth of the dopaminergic neurons' death. In fact, many types of neuronal cells besides dopaminergic neurons are involved in PD 19, 20 . For instance, during the neurodegenerative process of PD, some cholinergic nuclei are damaged as severely as and even earlier than dopaminergic neurons [19] [20] [21] . Unfortunately few studies have been done to determine the mechanism of cholinergic neuron degeneration in PD 12 . Since proteasome impairment has been believed to play an important role in the development of PD 1-3 , we are intrigued to figure out what effect it would exert on the cholinergic neurons. In our present study, it was demonstrated that proteasomal impairment by the proteasomal inhibitor Lact exerts cytotoxic effects on cultured cholinergic cells by causing mitochondrial dysfunction and subsequent oxidative stress, but not through polyubiquitinated protein accumulation.
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Figure 2: Effect of Lact on mitochondrial membrane potential. (A)-(F) Flow cytometry data with JC-1. (A) Negative control. (B) Control group. (C) Lact (1μM)-treated group. (D) Lact (5μM)-treated group. (E) Lact (10μM)-treated group. (F) Lact (20μM)-treated group. (G) Percentage
As shown here, cholinergic cells are sensitive to the proteasomal impairment and low doses of Lact are enough to induce cytotoxicity. The percentage of apoptotic cells reaches 16% at a dose of 1µM and 23% at a dose of 5µM, which is similar to that of undifferentiated PC12 cells 11 and primary rat midbrain dopaminergic neurons 22 respectively. Although it is not a direct comparison, it may suggest at least that cholinergic cells are vulnerable to the proteasomal inhibition. Another more interesting phenomenon is that doses higher than 5μM do not induce more cell death, somewhat may attenuate the situation implied by restoration of mitochondrial function and less production of ROS. Similar phenomena have recently been reported by Suh and his colleagues 23 . They found that murine cortical cell cultures exposed to 0.1µM MG132 underwent widespread neuronal apoptosis, but administration of 1-10µM MG132 resulted in reduced neuronal apoptosis. They suggested that these paradoxical effects of proteasome inhibitors depended on the degree of reduced proteasome activity; that is, partial blockade of proteasome activity led to activation of a mitochondria-dependent apoptotic signaling cascade, while complete blockade interfered with progression of apoptosis.
Would that be the case for cholinergic cells? Further investigation has to be done to figure it out and the underlying mechanism may be useful for preventing the degeneration of dopaminergic neurons.
The mechanism by which proteasome inhibitors induce apoptosis has been thoroughly researched. Mitochondrial dysfunction has been demonstrated by many researches. In cultured cortical neurons and sympathetic neurons, proteasome inhibitors have been shown to induce cell death by a mitochondria-dependent apoptotic mechanism [23] [24] [25] . In neuroblastoma SH-SY5Y cells, mitochondria homeostasis and mitochondria turnover are altered by proteosome inhibitors 26 . They can also induce the apoptosis of glioma cell lines by releasing cytochrome c and activating multiple caspases 27, 28 . Our data indicate that Lact definitely disturbed the mitochondrial membrane potential in cultured murine cholinergic SN56 cells, and 5μM Lact reached the damage peak.
Another hypothesis is that proteasomal dysfunction causes or augments oxidative and nitrative stress 29 . The study by Kikuchi et al 30 has shown that proteasome inhibitor could augment oxidative stress by producing more ROS, and some researchers have reported that proteasomal inhibition hypersensitized the dopaminergic cells to oxidative injury 31, 32 . However, Yamamoto et al 33 have recently suggested that proteasome inhibition protected cells from oxidative stress by inducing glutathione synthesis. Our study demonstrates that Lact induced oxidative stress in SN56 cells by producing ROS. With the doses increasing, the extent of oxidative stress attenuated rather than aggravated, suggesting that proteasome inhibition might have dual effects on oxidative stress. Whether intraneuronal inclusion bodies are toxic or non-toxic or even protective to neurons has been intensely debated 34, 35 . Previously, it was believed that either ubiquitinated inclusions or Lewy bodies are toxic to neurons, because they occur with the loss of neurons 34, 35 . However, evidence shows that Lewy bodies in substantia nigra neurons are absent in most patients with autosomal recessive juvenile parkinsonism 36, 37 . Some authors have argued that the formation of inclusion bodies and the toxicity of proteasome inhibitors are probably two parallel pathways 38, 39 . Obviously, in our study, proteasomal inhibition does not exert its toxin through accumulating the polyubiquitinated proteins; contrarily, it may somewhat suggest that the process of polyubiquitinated protein accumulating is beneficial to cholinergic cells, because with the doses higher than 5µM, the death rate does not increase further, whereas the mitochondrial function has restored and oxidative stress has attenuated slightly but significantly.
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CONCLUSIONS
To summarize, lactacystin induced mitochondrial dysfunction and apoptotic cell death in cholinergic cells. It also produced oxidative stress and the accumulation of polyubiquitinated proteins, but the latter does not appear to be responsible for cell degeneration.
